'The Story I Never Thought I Would Tell': Becky Quick Talks About Child's Rare Disease

Summary

CNBC anchor Becky Quick shares her family's experience raising daughter Kaylie, who has the ultra-rare genetic disorder SYNGAP1. The episode details the diagnostic odyssey, daily care challenges, and the lack of treatments for most rare diseases. It also discusses the collective size of the rare disease population, AI-driven scientific advances, and the need for more capital, collaboration, and regulatory attention. No specific securities, tickers, or investment recommendations are provided.

• Becky Quick opens up about her daughter Kaylie's diagnosis with SYNGAP1, an ultra-rare genetic disorder.
• Rare diseases are more than 10,000 conditions affecting about 30 million Americans, but individual diseases have small patient populations.
• Families face long diagnostic odysseys, limited information, and few FDA-approved treatment options.
• Scientific advances and AI are accelerating therapy development, though patients and families say progress remains too slow.
• Becky and Matt Quayle argue the rare disease mission should attract more money, research collaboration, and regulatory attention.
• The episode launches CNBC Cures to build community and highlight bottlenecks in rare disease treatment.
• No specific stocks, ETFs, or investment vehicles are named.